Safety and Tolerability Study to Evaluate Lower Dose of GSK2248761 in Antiretroviral Treatment-Naive HIV-1 Infected Adults.

Clinical trial NCT00945282 · COMPLETED

Trial details

NCT number: NCT00945282
Sponsor: ViiV Healthcare
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Infection, Human Immunodeficiency Virus

Start date: 2009-10-20
Primary completion: 2009-11-28
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.